⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8396732 | 1.00 | — | — | |
| SCHEMBL29086542 | 0.97 | — | — | |
| SCHEMBL29158521 | 0.97 | — | — | |
| SCHEMBL30088521 | 0.97 | — | — | |
| Water SCHEMBL8722365 | 0.97 | — | — | |
| Potassium SCHEMBL29704193 | 0.97 | — | — | |
| Charcoal, Activated SCHEMBL7974835 | 0.97 | — | — | |
| Water SCHEMBL1325514 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL4017637 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL7006678 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2003526654-A | — | — | 2003-09-09 | — | — | JP | claimed |
| EP-1263414-A1 | PHARMACEUTICAL COMPOSITIONS OF GLYCOGEN PHOSPHORYLASE INHIBITORS | Pfizer Products Inc. (US) | 2002-12-11 | — | — | EP | claimed |
| WO-2001068055-A1 | PHARMACEUTICAL COMPOSITIONS OF GLYCOGEN PHOSPHORYLASE INHIBITORS | PFIZER PRODUCTS INC. (US) | 2001-09-20 | — | — | WO | claimed |
| US-5952322-A | AMIDE-SUBSTITUTED BENZIMIDAZOLE, INDOLE DERIVATIVES | PFIZER INC. (US) | 1999-09-14 | — | — | US | claimed |
| CN-117940399-A | Heteroaryl or aryl substituted bisphenol compounds and thermoplastic resins | 三菱瓦斯化学株式会社 | 2024-04-26 | — | — | CN | disclosed |
| CN-112204028-B | tetrahydro-1H-pyrazino [2,1-a ] isoindoloquinoline compounds for use in the treatment of autoimmune diseases | 豪夫迈·罗氏有限公司 | 2023-12-29 | — | — | CN | disclosed |
| EP-4161937-A1 | PYRIDO[2,3-B] [1,4] OXAZINES OR TETRAHYDROPYRIDO[2,3-B][1,4] OXAZEPINES AS IAP ANTAGONISTS | BeiGene, Ltd. (KY) | 2023-04-12 | — | — | EP | disclosed |
| CN-115066438-A | ASGPR binding compounds for degrading extracellular proteins | 阿维拉治疗公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-114380845-A | Heterocyclic-fused compound, pharmaceutical composition containing same, preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2022-04-22 | — | — | CN | disclosed |
| CN-112204028-A | tetrahydro-1H-pyrazino [2,1-a ] isoindolyl quinoline compounds for the treatment of autoimmune diseases | 豪夫迈·罗氏有限公司 | 2021-01-08 | — | — | CN | disclosed |
| CN-112020500-A | Aminopyridine derivatives as inhibitors of phosphatidylinositol phosphokinase | 拉文纳制药公司 | 2020-12-01 | — | — | CN | disclosed |
| CN-111936484-A | Chromenopyridine derivatives as inhibitors of phosphatidylinositol phosphokinase | 拉文纳制药公司 | 2020-11-13 | — | — | CN | disclosed |
| CN-109134438-B | 1-phenazinyl (phenyl) (5-pyrimidinyl) methanol compound and preparation method and application thereof | 长江大学 | 2020-10-09 | — | — | CN | disclosed |
| EP-1263414-A1 | PHARMACEUTICAL COMPOSITIONS OF GLYCOGEN PHOSPHORYLASE INHIBITORS | Pfizer Products Inc. (US) | 2002-12-11 | — | — | EP | disclosed |
| WO-2001068055-A1 | PHARMACEUTICAL COMPOSITIONS OF GLYCOGEN PHOSPHORYLASE INHIBITORS | PFIZER PRODUCTS INC. (US) | 2001-09-20 | — | — | WO | disclosed |
| US-5952322-A | AMIDE-SUBSTITUTED BENZIMIDAZOLE, INDOLE DERIVATIVES | PFIZER INC. (US) | 1999-09-14 | — | — | US | disclosed |
| US-5863924-A | Aryl pyrimidine derivatives | SYNTEX (U.S.A.) INC. (US) | 1999-01-26 | — | — | US | disclosed |